| Christine H Le, OD | |
|
3000 184th St Sw Ste 210, Lynnwood, WA 98037-4719 | |
| (425) 776-8234 | |
| (425) 484-0064 |
| Full Name | Christine H Le |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 13 Years |
| Location | 3000 184th St Sw Ste 210, Lynnwood, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053692905 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 60244629 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Encore Eye Care, Inc | 5092982587 | 2 |
News Archive
Appropriate use of testing is a hot topic in medicine as physicians and hospitals look for ways to improve quality while containing cost to achieve high-value care. This is especially true in the field of cardiology where the potential consequences of incorrect diagnosis have led to overuse of cardiovascular imaging with CT scanners, called coronary CT angiography.
People with advanced gastrointestinal stromal tumors (GIST) who take Gleevec (imatinib) for prolonged periods continue to benefit from the drug, according to a five-year study by Oregon Health & Science University Cancer Institute researchers.
To coincide with World Hepatitis Day, a new report, commissioned by United European Gastroenterology, calls for all European countries to adopt universal vaccination and harmonised screening programmes for hepatitis, as well as improved neonatal screening, to help speed up the eradication of the disease.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that combination treatment with milatuzumab, the first humanized anti-CD74 antibody in clinical testing, and veltuzumab, a second-generation humanized anti-CD20 antibody, resulted in therapeutic responses in heavily pretreated and rituximab-refractory non-Hodgkin's lymphoma patients.
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
› Verified 2 days ago
| Provider Name | Encore Eye Care, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922377753 PECOS PAC ID: 5092982587 Enrollment ID: O20120124000935 |
News Archive
Appropriate use of testing is a hot topic in medicine as physicians and hospitals look for ways to improve quality while containing cost to achieve high-value care. This is especially true in the field of cardiology where the potential consequences of incorrect diagnosis have led to overuse of cardiovascular imaging with CT scanners, called coronary CT angiography.
People with advanced gastrointestinal stromal tumors (GIST) who take Gleevec (imatinib) for prolonged periods continue to benefit from the drug, according to a five-year study by Oregon Health & Science University Cancer Institute researchers.
To coincide with World Hepatitis Day, a new report, commissioned by United European Gastroenterology, calls for all European countries to adopt universal vaccination and harmonised screening programmes for hepatitis, as well as improved neonatal screening, to help speed up the eradication of the disease.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that combination treatment with milatuzumab, the first humanized anti-CD74 antibody in clinical testing, and veltuzumab, a second-generation humanized anti-CD20 antibody, resulted in therapeutic responses in heavily pretreated and rituximab-refractory non-Hodgkin's lymphoma patients.
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine H Le, OD 5900 Lake Washington Blvd Se, Bellevue, WA 98006-2635 Ph: (425) 353-0404 | Christine H Le, OD 3000 184th St Sw Ste 210, Lynnwood, WA 98037-4719 Ph: (425) 776-8234 |
News Archive
Appropriate use of testing is a hot topic in medicine as physicians and hospitals look for ways to improve quality while containing cost to achieve high-value care. This is especially true in the field of cardiology where the potential consequences of incorrect diagnosis have led to overuse of cardiovascular imaging with CT scanners, called coronary CT angiography.
People with advanced gastrointestinal stromal tumors (GIST) who take Gleevec (imatinib) for prolonged periods continue to benefit from the drug, according to a five-year study by Oregon Health & Science University Cancer Institute researchers.
To coincide with World Hepatitis Day, a new report, commissioned by United European Gastroenterology, calls for all European countries to adopt universal vaccination and harmonised screening programmes for hepatitis, as well as improved neonatal screening, to help speed up the eradication of the disease.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that combination treatment with milatuzumab, the first humanized anti-CD74 antibody in clinical testing, and veltuzumab, a second-generation humanized anti-CD20 antibody, resulted in therapeutic responses in heavily pretreated and rituximab-refractory non-Hodgkin's lymphoma patients.
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
› Verified 2 days ago
Dr. Patrick Sung, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3000 184th St Sw Ste 206, Lynnwood, WA 98037 Phone: 425-775-6069 | |
Dr. Aqil Habib, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2701 184th St Sw, Suite 109, Lynnwood, WA 98037 Phone: 425-712-8443 | |
Dr. Willow Frances Thompson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16006 Ash Way Ste 101, Lynnwood, WA 98087 Phone: 425-787-5200 Fax: 425-787-5252 | |
Jason Alan Sifrit, O.D., F.A.A.O. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3000 184th St Sw Ste 206, Lynnwood, WA 98037 Phone: 425-776-8234 Fax: 425-776-8481 | |
Xiang Jun Dong, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3333 184th St Sw # P, Lynnwood, WA 98037 Phone: 425-744-1177 | |
Dr. John R Pfeifer, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 18631 Alderwood Mall Pkwy, #105, Lynnwood, WA 98037 Phone: 425-771-2662 Fax: 425-670-2333 |